Stay updated with breaking news from Technology Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There has been impressive progress on the vaccination front. Scientists have come up with multiple vaccines in record time. Unprecedented public and private financing has supported vaccine research, development and manufacturing scale-up.
English News and Press Release on World about Health and Epidemic; published on 31 May 2021 by WHO
A dangerous gap is emerging between richer and poorer nations' recovery, and the longer we wait to act, the costlier action becomes in human suffering and economic losses.
A small number of pharmaceutical companies with the support of developed country governments invested billions of dollars in research and development of COVID-19 vaccines, related medicines, and technologies including mRNA, DNA, RNA, viral vector, protein subunit and testing materials along with their production and distribution.
I do not think that the waiver will help us overcoming the current vaccine shortage. The first problem is that there is not enough infrastructure – manufacturing facilities, equipment, personnel – to expand vaccine production to the levels it should be at to meet pandemic demand. In this context, altering the intellectual property status quo does little – Ana Santos Rutschman, assistant professor at the Saint Louis University School of Law pointed out in a conversation with Lénárd Sándor, researcher at the National University of Public Service. Ana Santos RUTSCHMAN is assistant p...